Cargando…
Evaluation of a Pharmacist-Managed Amiodarone Monitoring Program
BACKGROUND: Because of the potential for serious adverse effects, patients treated with amiodarone must be carefully screened and routinely monitored for potential liver, thyroid, and pulmonary toxicity. However, laboratory and pulmonary monitoring rates have been found to be substantially lower tha...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437408/ https://www.ncbi.nlm.nih.gov/pubmed/21870892 http://dx.doi.org/10.18553/jmcp.2011.17.7.513 |